Trademark Overview
On Wednesday, July 17, 2024, a trademark application was filed for TAGEOM with the United States Patent and Trademark Office. The USPTO has given the TAGEOM trademark a serial number of 79406809. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, October 17, 2024. This trademark is owned by NOVARTIS AG. The TAGEOM trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Pharmaceutical and medical preparations and medical devices sold pre-filled with pharmaceutical preparations, all for the prevention and treatment of renal diseases and disorders, inflammatory diseases and disorders, dermatological diseases and disorders, gastrointestinal diseases and disorders, respiratory diseases and disorders, complement-mediated diseases and disorders, neoplastic diseases and disorders, bone diseases and disorders, diseases and disorders of the immune system, the cardiovascular system, the musculo-skeletal system, the genitourinary system, the central nervous system, the endocrine system, the metabolic system and the circulatory system
Autoinjectors for the administration of pharmaceutical preparations